Morgan Stanley Sticks to Its Buy Rating for Giant Biogene Holding Co. Ltd. (2367)
I'm PortAI, I can summarize articles.
Morgan Stanley has maintained a Buy rating for Giant Biogene Holding Co. Ltd. with a price target of HK$42.00, while the current share price is HK$34.72. Citi also issued a Buy rating earlier, whereas UBS maintained a Hold rating. This reflects mixed analyst opinions on the company's stock performance.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments